Trial
NCT02973711
A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
—
Condition
Leukemia, Chronic Myeloid
Intervention
Nilotinib
Why stopped
lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-16